BackgroundThis study compared the performance of five commercially available kits in extracting total RNA from small eukaryotic tissue samples (<15?mg). Total RNA was isolated from fathead minnow (Pimephales promelas) tissues (spleen, blood, kidney, embryo, and larvae) using the Qiagen RNeasy? Plus Mini, Qiagen RNeasy? Plus Universal, Promega Maxwell? 16 LEV simplyRNA, Ambion MagMAX?-96 and Promega SimplyRNA HT kits. Kit performance was evaluated via measures of RNA quantity (e.g., total RNA amount) and quality (e.g., ratio of absorbance at 260 and 280?nm, RNA integrity number (RIN), presence of gDNA).ResultsWith the exception of embryos, each kit generally extracted ?5??g of total RNA from each sample. With regard to RNA quality, the RINs of RNA samples isolated via the Plus Mini and Maxwell? 16 kits were consistently higher than those of samples extracted via the remaining three kits and for all tissues, these kits produced intact RNA with average RIN values ?7. The Plus Universal and SimplyRNA HT kits produced moderately degraded (RIN values <7, but ?5), while the RNA recovered via the MagMAX? kit tended to exhibit a high degree of degradation (RIN values <5).ConclusionsEach kit was generally capable of extracting the amount of RNA required for most downstream gene expression applications suggesting that RNA yield is unlikely to be a limiting factor for any of the kits evaluated. However, differences in the quality of RNA extracted via each of the kits indicate that these kits may differ in their ability to yield RNA acceptable for some applications. Overall, the findings of this study demonstrate that there are practical differences between commercially available RNA extraction kits that should be taken into account when selecting extraction methods to be used for isolating RNA designated for gene expression analysis.
-
BackgroundThis study compared the performance of five commercially available kits in extracting total RNA from small eukaryotic tissue samples (<15?mg). Total RNA was isolated from fathead minnow (Pimephales promelas) tissues (spleen, blood, kidney, embryo, and larvae) using the Qiagen RNeasy? Plus Mini, Qiagen RNeasy? Plus Universal, Promega Maxwell? 16 LEV simplyRNA, Ambion MagMAX?-96 and Promega SimplyRNA HT kits. Kit performance was evaluated via measures of RNA quantity (e.g., total RNA amount) and quality (e.g., ratio of absorbance at 260 and 280?nm, RNA integrity number (RIN), presence of gDNA).ResultsWith the exception of embryos, each kit generally extracted ?5??g of total RNA from each sample. With regard to RNA quality, the RINs of RNA samples isolated via the Plus Mini and Maxwell? 16 kits were consistently higher than those of samples extracted via the remaining three kits and for all tissues, these kits produced intact RNA with average RIN values ?7. The Plus Universal and SimplyRNA HT kits produced moderately degraded (RIN values <7, but ?5), while the RNA recovered via the MagMAX? kit tended to exhibit a high degree of degradation (RIN values <5).ConclusionsEach kit was generally capable of extracting the amount of RNA required for most downstream gene expression applications suggesting that RNA yield is unlikely to be a limiting factor for any of the kits evaluated. However, differences in the quality of RNA extracted via each of the kits indicate that these kits may differ in their ability to yield RNA acceptable for some applications. Overall, the findings of this study demonstrate that there are practical differences between commercially available RNA extraction kits that should be taken into account when selecting extraction methods to be used for isolating RNA designated for gene expression analysis. -
Finished PDF is out: http://www.biomedcentral.com/1472-6750/14/94/abstract
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment